Menopause is a natural stage of life, yet for many women it can bring significant physical and emotional changes. Symptoms such as hot flushes, disturbed sleep, brain fog, mood changes, vaginal dryness, joint aches and skin ageing can have a substantial impact on quality of life.
Hormone Replacement Therapy (HRT) remains one of the most effective treatments for menopausal symptoms. However, many women still have concerns about its safety following widespread publicity surrounding the Women’s Health Initiative (WHI) study published in 2002.
More than twenty years later, our understanding of menopause and hormone therapy has evolved considerably.
The Study That Changed the Conversation
The Women’s Health Initiative (WHI) was one of the largest studies ever conducted in postmenopausal women. The study reported an increased risk of breast cancer, blood clots, stroke and cardiovascular events in women taking a specific form of combined oestrogen and progestin therapy.
The findings received extensive media coverage and led many women to stop taking HRT. Prescribing rates fell dramatically worldwide, and many healthcare professionals became increasingly cautious about recommending hormone therapy.
The WHI remains an important study. However, subsequent analysis revealed that the initial interpretation did not tell the whole story.
What Researchers Learned Later
One of the most important findings was that the women enrolled in the WHI study were not necessarily representative of women who typically seek HRT for menopausal symptoms today.
The average participant was approximately 63 years old, and many women were more than ten years beyond menopause when hormone therapy was initiated. Researchers later recognised that age, timing and baseline health status significantly influence both the benefits and risks of treatment. Women in the study were often asymptomatic, older and had differing cardiovascular risk profiles from women who usually begin treatment around the onset of menopause.
Subsequent research has shown that age, time since menopause, hormone type, dose, route of administration and individual health status all matter when assessing suitability for HRT. This has led to the concept of the “timing hypothesis” – the understanding that women who begin treatment closer to menopause may experience a different risk-benefit profile compared with those who start many years later.
What Current Guidance Says
Today, leading menopause organisations generally support the use of appropriately prescribed HRT for many healthy women who are under 60 years of age or within ten years of menopause, following an individual assessment of risks and benefits.
Evidence reviewed by the British Menopause Society and Women’s Health Concern suggests that HRT started before age 60 or within ten years of menopause may be associated with favourable cardiovascular outcomes and improvements in quality of life for suitable women.
This does not mean HRT is right for everyone.
Every woman should be assessed individually, taking into account:
• Personal medical history
• Family history
• Breast cancer risk
• Cardiovascular health
• Blood clotting risk
• Lifestyle factors
• Severity of symptoms
• Personal treatment goals
Modern menopause medicine is increasingly personalised rather than based on a one-size-fits-all approach.
HRT and Breast Cancer Risk
Breast cancer risk is an important part of any HRT discussion.
Current evidence suggests that risk varies according to the type of hormone therapy used, the duration of treatment, a woman’s age and her personal health history.
Combined HRT containing both oestrogen and a progestogen may be associated with a small increase in breast cancer risk with longer-term use, while oestrogen-only therapy appears to have a different risk profile in women who have had a hysterectomy. Women with a personal history of breast cancer usually require specialist advice before considering hormone therapy. Individual assessment remains essential.
Importantly, breast health should be viewed within the wider context of overall health. Genetics, family history, body weight, alcohol consumption, physical activity, breast density and reproductive history all influence risk.
Menopause and Skin Ageing
Menopause affects much more than reproductive health.
Oestrogen plays a vital role in maintaining collagen production, skin thickness, hydration, elasticity and wound healing.
As oestrogen levels decline, collagen production falls significantly. Research suggests women may lose up to 30% of skin collagen during the first five years after menopause. This contributes to thinner skin, dryness, reduced elasticity, slower wound healing and the visible signs of ageing.
Many women notice that skin changes accelerate during the menopausal transition. While HRT is not prescribed solely for cosmetic purposes, appropriate hormone therapy may help support some of these physiological changes in suitable candidates as part of its wider health effects.
The Foundations of Healthy Ageing
Whether or not HRT is appropriate for an individual woman, lifestyle remains one of the most powerful tools available to support healthy ageing.
Nutrition
Research consistently supports a nutrient-dense dietary pattern rich in vegetables, fibre, legumes, fruit, healthy fats and quality protein. Maintaining a healthy body weight is particularly important, as excess body fat is associated with increased breast cancer risk after menopause. Diets rich in antioxidants, fibre, omega-3 fatty acids and plant-based foods may support both breast health and overall wellbeing.
Exercise
Regular physical activity is one of the most evidence-based lifestyle interventions for healthy ageing. Exercise supports cardiovascular health, muscle mass, insulin sensitivity, bone density, cognitive function and emotional wellbeing.
Strong evidence suggests that regular physical activity is associated with a reduced risk of postmenopausal breast cancer. Resistance training is particularly important as women age because it helps preserve muscle mass, strength, balance and metabolic health.
Sleep
Sleep is often overlooked during menopause, yet it is essential for recovery, immune function, cognitive health, hormone regulation and emotional wellbeing. Poor sleep can affect appetite regulation, blood sugar balance, stress hormones and overall quality of life.
Addressing sleep disturbances is often a key part of a comprehensive menopause management plan.
Stress Management
Chronic stress may contribute to inflammation, poor sleep, weight gain, emotional distress and reduced resilience. Practical strategies such as mindfulness, breathing exercises, time in nature, social connection, counselling, relaxation therapies and regular movement can all support healthy ageing and wellbeing.
Final Thoughts.
The Women’s Health Initiative changed the conversation around HRT, but it was not the final chapter.
Over the last two decades, researchers have gained a much deeper understanding of how age, timing, hormone type, dose, route of administration and individual health status influence outcomes.
Today, menopause care is increasingly personalised, evidence-based and centred on informed decision-making.
If you are experiencing menopausal symptoms, seek guidance from an experienced GP or healthcare professional with expertise in menopause management. Together, you can assess your individual health profile, discuss the potential benefits and risks, and determine the most appropriate approach for your needs.
Every woman is unique. The best decisions are informed decisions, based on current evidence, individual circumstances and personal goals.
Further Reading
Women’s Health Concern (British Menopause Society)
https://www.womens-health-concern.org
British Menopause Society
https://thebms.org.uk
Breast Cancer Research Foundation
https://www.bcrf.org
National Institute for Health and Care Excellence (NICE) Menopause Guidelines
https://www.nice.org.uk/guidance/ng23
Key References
- Women’s Health Concern: HRT Benefits and Risks
- British Menopause Society Consensus Statement on HRT
- Review of WHI interpretation and participant characteristics
- Breast Cancer Research Foundation: Diet, Nutrition and Breast Cancer
- World Cancer Research Fund: Physical Activity, Weight and Breast Cancer Risk
- Mayo Clinic Menopause Hormone Therapy Guidance
